Vitiligo is an autoimmune condition in which cells known as melanocytes are killed off in certain areas of the skin. Melanocytes produce melanin, a substance which gives the skin its pigmentation.

A recent clinical trial found that combining the oral medication baricitinib with narrowband UV-B light therapy significantly ...

A natural compound derived from gut-friendly bacteria significantly slows the progression of vitiligo and may restore pigmentation, reports a new Northwestern University pre-clinical study in mice.

"This proof-of-concept randomized clinical trial highlighted the efficacy of combining the JAK1/JAK2 inhibitor baricitinib with narrowband UVB in the treatment of adults with active vitiligo," the ...

severe skin damage, hormonal changes like puberty, liver or kidney problems, or exposure to certain chemicals. There is no cure for vitiligo, but there are a variety of innovative treatments that ...

Living with vitiligo is challenging ... These infections may happen or become more severe if you use OPZELURA. Ask your healthcare provider if you do not know if you have lived in an area where ...

Discover a recent study that evaluated the efficacy and safety of combining baricitinib, with narrowband UV-B phototherapy in adults with severe, active, nonsegmental vitiligo.

Vitiligo is a skin condition characterized by ... unaffected skin to match vitiligo patches), or surgical options in severe cases. 5. Psychological Impact: Vitiligo can have significant ...

The Janus kinase inhibitor baricitinib, in combination with narrowband ultraviolet B therapy, improved vitiligo, according to ...

Lucknow: King George's Medical University (KGMU) will soon offer advanced treatment options for conditions such as vitiligo (leukoderma) and psoriasis.